BLACK DIAMOND THERAPEUTICS, INC. Increase (Decrease) in Due to Related Parties, Current
BLACK DIAMOND THERAPEUTICS, INC. (BDTX) reported Increase (Decrease) in Due to Related Parties, Current of $0 for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent · last filed 2021-11-08
- BLACK DIAMOND THERAPEUTICS, INC. increase (decrease) in due to related parties, current for the quarter ending 2021-09-30 was $0.00, a 100.00% decline year-over-year.
- BLACK DIAMOND THERAPEUTICS, INC. increase (decrease) in due to related parties, current for the quarter ending 2021-06-30 was $0.00.
- BLACK DIAMOND THERAPEUTICS, INC. increase (decrease) in due to related parties, current for the quarter ending 2021-03-31 was $0.00, a 100.00% decline year-over-year.
- BLACK DIAMOND THERAPEUTICS, INC. increase (decrease) in due to related parties, current for the quarter ending 2020-12-31 was -$190.00K.
- BLACK DIAMOND THERAPEUTICS, INC. increase (decrease) in due to related parties, current for fiscal 2020 was $0.00.
- BLACK DIAMOND THERAPEUTICS, INC. increase (decrease) in due to related parties, current for fiscal 2019 was -$1.71M.
- BLACK DIAMOND THERAPEUTICS, INC. increase (decrease) in due to related parties, current for fiscal 2018 was -$213.00K.
| Period end | Increase (Decrease) in Due to Related Parties, Current 3 month | Increase (Decrease) in Due to Related Parties, Current 6 month | Increase (Decrease) in Due to Related Parties, Current 9 month | Increase (Decrease) in Due to Related Parties, Current 12 month |
|---|---|---|---|---|
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $0.00 derived: sum of 2 quarters · filed 2021-11-08 | $0.00 10-Q · filed 2021-11-08 | -$190.00K derived: sum of 4 quarters · filed 2021-11-08 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $0.00 10-Q · filed 2021-08-12 | -$190.00K derived: sum of 3 quarters · filed 2021-08-12 | -$15.00K derived: sum of 4 quarters · filed 2021-11-08 |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-07 | -$190.00K derived: sum of 2 quarters · filed 2021-05-07 | -$15.00K derived: sum of 3 quarters · filed 2021-11-08 | -$964.00K derived: sum of 4 quarters · filed 2021-11-08 |
| 2020-12-31 | -$190.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | -$15.00K derived: sum of 2 quarters · filed 2021-11-08 | -$964.00K derived: sum of 3 quarters · filed 2021-11-08 | $0.00 10-K · filed 2021-03-25 |
| 2020-09-30 | $175.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | -$774.00K derived: sum of 2 quarters · filed 2021-11-08 | $190.00K 10-Q · filed 2021-11-08 | -$1.06M derived: sum of 4 quarters · filed 2021-11-08 |
| 2020-06-30 | -$949.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $15.00K 10-Q · filed 2021-08-12 | -$1.24M derived: sum of 3 quarters · filed 2021-08-12 | -$55.00K derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | $964.00K 10-Q · filed 2021-05-07 | -$290.00K derived: sum of 2 quarters · filed 2021-05-07 | $894.00K derived: sum of 3 quarters · filed 2021-05-07 | $964.00K derived: sum of 4 quarters · filed 2021-05-07 |
| 2019-12-31 | -$1.25M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | -$70.00K derived: sum of 2 quarters · filed 2021-03-25 | $0.00 derived: sum of 3 quarters · filed 2021-03-25 | -$1.71M 10-K · filed 2021-03-25 |
| 2019-09-30 | $1.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $1.25M derived: sum of 2 quarters · filed 2020-11-10 | -$453.00K 10-Q · filed 2020-11-10 | |
| 2019-06-30 | $70.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11 | -$1.64M 10-Q · filed 2020-08-11 | ||
| 2019-03-31 | -$1.71M 10-Q · filed 2020-05-12 | |||
| 2018-12-31 | -$213.00K 10-K · filed 2020-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |